Online citations, reference lists, and bibliographies.
← Back to Search

Can Early Palliative Care With Anticancer Treatment Improve Overall Survival And Patient-related Outcomes In Advanced Lung Cancer Patients? A Review Of The Literature

M. Ambroggi, C. Biasini, Ilaria Toscani, E. Orlandi, R. Bertè, Martina Mazzari, L. Cavanna
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PurposeMetastatic non-small-cell lung cancer (NSCLC), the leading cause of death from cancer worldwide, is a debilitating disease that results in a high burden of symptoms and poor quality of life; the estimated prognosis after the diagnosis has been established was less than 1 year until some years ago. At the present, the new targeted therapies and immunotherapy are changing the course of the disease. However, advanced NSCLC remains an incurable disease, with a poor prognosis for the majority of the affected patients, so that quality of life and relief from symptoms are primary objectives of treatment. Some evidences suggest that early palliative care (EPC) for these patients can improve quality of life and even survival.DesignA systematic review of the studies evaluating the impact on objective and on patient-reported outcomes of the introduction of EPC in opposition to standard care (SC), for advanced lung cancer patients, was performed. Because of the small number of studies conducted in this area, retrospective studies were also considered for the review.ResultsFive studies were included because they matched the inclusion criteria previously defined as relevant for the study. The review found that both survival and quality of life were better for patients included in EPC groups.ConclusionsWhile results of the studies included in this review are not always comparable because different methods and scales have been used, there is enough evidence for clinical oncologists to implement the use of EPC in clinical practice for advanced lung cancer patients.
This paper references
Support Care Cancer
AA Wright (2008)
10.1089/109662101750290191
Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital.
S. Lutz (2001)
Associations between end-of-life discussions, patient Support Care Cancer mental health, medical care near death, and caregiver bereavement adjustment
AA Wright (2008)
10.1200/JCO.2008.19.6543
The role of investigational therapy in management of patients with advanced metastatic malignancy.
E. Freireich (2009)
10.1016/S1470-2045(11)70393-X
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
R. Rosell (2012)
PROFILE 1014 investigators . First - line crizotinib versus chemotherapy in ALK - positive lung cancer
J Mazieres (2015)
10.1002/cncr.24942
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center
D. Hui (2010)
10.5301/tj.5000593
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care)
V. Zagonel (2017)
10.1007/s00520-016-3278-z
Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer
C. Nieder (2016)
10.1056/NEJMoa1000678
Early palliative care for patients with metastatic non-small-cell lung cancer.
J. Temel (2010)
METas a possible target for non-smallcell lung cancer
AA Sadiq (2013)
10.1016/j.jpainsymman.2008.09.011
Late referrals to palliative care units in Japan: nationwide follow-up survey and effects of palliative care team involvement after the Cancer Control Act.
T. Morita (2009)
10.1200/JCO.2000.18.4.893
Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.
Penny Hopwood (2000)
10.1017/S1478951509000108
The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions.
Marie Bakitas (2009)
10.1634/theoncologist.2015-0110
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature.
M. Ambroggi (2015)
Effects of early palliative care in patients with lung and GI cancer: a randomized clinical trial
JS Temel (2017)
10.1056/NEJMoa1504627
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
J. Brahmer (2015)
10.1038/bjc.1995.124
Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
P. Hopwood (1995)
The problem of caring for the dying in a general hospital; the palliative care unit as a possible solution.
B. Mount (1976)
Early palliative care for patients with advanced cancer: a clusterrandomised controlled trial
C Zimmermann (2014)
patients : a retrospective cohort study
N Fadul (2009)
10.1093/med/9780190658618.003.0006
Availability and Integration of Palliative Care at US Cancer Centers (DRAFT)
Pedro E Perez-Cruz (2018)
10.1089/JPM.2005.8.1025
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.
W. Cheng (2005)
10.1200/JCO.2010.29.5618
Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care.
E. Bruera (2010)
10.1200/JCO.2006.09.2627
Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
J. Temel (2007)
10.1089/jpm.2009.0166
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.
D. Hui (2010)
PROFILE 1014 Investigators (2014) PROFILE 1014 investigators. First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon (2014)
10.1200/JCO.2005.12.107
Late referrals to specialized palliative care service in Japan.
T. Morita (2005)
10.1097/SPC.0b013e328325a5ab
The assessment and management of family distress during palliative care
T. Zaider (2009)
10.1089/109662102753641331
Palliative care models: international perspective.
E. Bruera (2002)
10.1016/j.jpainsymman.2016.01.003
Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review.
J. King (2016)
10.1089/JPM.2006.0257
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center.
F. Braiteh (2007)
10.1016/S0885-3924(02)00599-7
Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers?
I. Higginson (2003)
10.1056/NEJMoa0810699
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
T. Mok (2009)
10.1001/jama.300.14.1665
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.
A. Wright (2008)
10.1002/cncr.24206
Supportive versus palliative care: What's in a name?
N. Fadul (2009)
10.1016/S0885-3924(01)00406-7
Do hospital-based palliative teams improve care for patients or families at the end of life?
I. Higginson (2002)
World Health Organization: National Cancer Control Programmes: policies and managerial guidelines
10.1016/J.JPAINSYMMAN.2003.10.011
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study.
F. Strasser (2004)
10.1001/jama.2010.258
Availability and integration of palliative care at US cancer centers.
D. Hui (2010)
10.1200/JCO.2014.58.3302
Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
J. Mazieres (2015)
10.1016/S0140-6736(15)01281-7
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
R. Herbst (2016)
center
A Jemal (2009)
2015)Nivolumab versus docetaxel in advanced nonsquamous nonsmall-cell lung Cancer
H Borghaei (2015)
10.1200/jco.2010.28.15_suppl.9062
Timing of palliative care referral and symptom burden in phase I cancer patients: A retrospective cohort study.
H. Parsons (2010)
10.1089/jpm.2007.0103
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center.
B. Osta (2008)
10.22605/RRH1146
Disparity in cancer survival between urban and rural patients--how can clinicians help reduce it?
S. Sabesan (2009)
10.1089/JPM.2006.9.391
Symptom control in palliative care--Part I: oncology as a paradigmatic example.
S. Dalal (2006)
10.1056/NEJMoa1507643
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
H. Borghaei (2015)
10.3322/canjclin.39.6.399
Cancer statistics
N. Dubrawsky (1989)
admit - ted to an acute palliative care unit at a comprehensive cancer center : a simultaneous care model
D Hui (2010)
10.7326/0003-4819-151-4-200908180-00136
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
A. Liberati (2009)
10.1056/NEJMoa1214886
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
A. Shaw (2013)



This paper is referenced by
10.5388/AON.2018.18.4.198
Comparison of Life-Sustaining Treatment in Terminal Cancer Patients between a Cancer and Hospice Unit after Do-Not-Resuscitate Orders
E. J. Nam (2018)
PROM_A_238009 67..71
A. Matsuda (2020)
10.1136/bmjopen-2019-035673
Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study
R. B. Friis (2020)
10.1371/journal.pone.0226597
Does early palliative identification improve the use of palliative care services?
N. Mittmann (2020)
10.21037/TLCR.2019.11.33
Multidisciplinary team care in advanced lung cancer.
A. Kowalczyk (2020)
10.2147/PROM.S179185
Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer
L. Cavanna (2020)
10.1007/978-981-15-2521-6
Primary Care Revisited: Interdisciplinary Perspectives for a New Era
Yuk Fai Fong (2020)
10.15761/TIM.1000198
Quantification of quality of life improvement after appropriate symptoms control in cancer patients with breakthrough pain: A four-week follow-up study in a palliative care unit
Miguel Ángel Núñez Viejo (2019)
10.1177/0269216320916154
Palliative care in the context of immune and targeted therapies: A qualitative study of bereaved carers’ experiences in metastatic melanoma
J. Fox (2020)
10.1186/s12904-020-00568-3
Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)
N. Harnischfeger (2020)
10.7150/jca.30463
Prognostic value of site-specific metastases in lung cancer: A population based study
J. Li (2019)
10.1007/s11864-020-0702-x
How Effective Is Palliative Care in Improving Patient Outcomes?
Sarah Milazzo (2020)
10.1002/pon.5076
Integrating early palliative care into routine practice for patients with cancer: A mixed methods evaluation of the INTEGRATE Project
Jenna M Evans (2019)
10.2147/PROM.S238009
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study
M. Vollmann (2020)
10.1097/MD.0000000000017683
Knowledge and attitudes toward end-of-life care among community health care providers and its influencing factors in China
Hongrui Shi (2019)
Semantic Scholar Logo Some data provided by SemanticScholar